Mukaltin (Mucaltin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For 1 tablet:

of the active substance: althaea medicinal roots extract (mucaltin) 50 mg,

excipients: sodium bicarbonate 87 mg, tartaric acid 160.0 mg, calcium stearate 3.0 mg.

Description:

Round, flat-cylindrical tablets, from light gray to brownish-gray with interspersed, with a specific smell, with a facet and a risk.

Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Expectorants
    • Pharmacodynamics:

    Mukaltin is a mixture of polysaccharides from the herb althea medicinal, possesses expectorant properties. Thanks to reflex stimulation, it intensifies the activity of the ciliated epithelium and the peristalsis of respiratory bronchioles in combination with increased secretion of the bronchial glands.

    Indications:

    Acute and chronic diseases of the respiratory tract, accompanied by a cough with hard to remove sputum of increased viscosity (tracheobronchitis, obstructive bronchitis, bronchiectasis, pneumonia, etc.) - as part of complex therapy.

    Contraindications:

    Hypersensitivity to the components of the drug, peptic ulcer of the stomach and duodenum, children under 12 years.

    Pregnancy and lactation:

    The use of the drug during pregnancy and during breastfeeding is possible on the advice of a doctor.

    Dosing and Administration:

    Inside adults and children from 12 years: 1-2 tablets 2-3 times a day before meals.

    The average course of treatment is 7-14 days.

    Children can dissolve the pill in 1/3 cup of warm water.

    Side effects:

    Allergic reactions; rarely - dyspeptic phenomena.

    Overdose:

    To date, cases of overdose with the use of the drug are not registered.

    Interaction:

    Mucaltin can be prescribed concomitantly with other drugs used in the treatment of bronchopulmonary diseases.

    Mucaltin should not be used concomitantly with drugs containing codeine and other antitussive medicines, as this makes it difficult to cough up thinned phlegm.

    Form release / dosage:Tablets, 50 mg.
    Packaging:

    For 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.

    For 6 or 10 tablets in a contour non-cellular package of paper with a polymer coating.

    By 20, 30, 40, 50 or 60 tablets in cans of polymeric with screw caps or in polymeric bottles with screw caps.

    Each jar or bottle together with the instruction for use is placed in a pack of cardboard.

    For 1, 2, 3, 4, 5 or 6 contour squares, together with the instructions for use, are placed in a pack of cardboard.

    By 2, 3, 4 or 5 contour non-jawed packages but 6 tablets together with instructions for use are placed in a pack of cardboard.

    According to 1, 2, 3, 4 or 5 contour non-jawed packages of 10 tablets together with the instruction for use are placed in a pack of cardboard.

    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-000573
    Date of registration:28.05.2010 / 19.02.2018
    Expiration Date:Unlimited
    The owner of the registration certificate:AVVA RUS, OJSC AVVA RUS, OJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspAVVA ENG JSC AVVA ENG JSC Russia
    Information update date: & nbsp31.05.2018
    Illustrated instructions
      Instructions
      Up